Oxy
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline to market Lavipharm Labs' patented anti-blemish patch under Oxy brand in UK, pharmaceutical technology firm says. Marketing for Oxy Dots transparent patches will stress they reduce appearance of blemishes while targeting blocked pores and germs, Lavipharm says. Global distribution plans under consideration. Lavipharm's other cosmetic patch partners include L'Oreal, Chattem, Unilever, Vichy
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning